YUHAN CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 124,800.00 KRW | +3.83% |
|
-10.60% | +81.40% |
| 08-22 | South Korean Shares Rise After BOK Rate Hold; Yuhan Gains on FDA Approval | MT |
| 08-22 | Yuhan Shares Jump 4% After US FDA Approves Anti-Cancer Drug for US Markets | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. EPS revision | 1m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | ||
|---|---|---|---|---|---|
| Average | |||||
| Weighted average by Cap. |
Turnover
Estimates Revisions:
Earnings Per Share (EPS)
Estimates Revisions:
EBIT
Estimates Revisions:
Dividend / Share (DPS)
Estimates Revisions:
Cash or Net Debt
Estimates Revisions:
- Stock Market
- Equities
- A000100 Stock
- Consensus Yuhan Corporation
- Estimates Revisions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition